HCAT SEC Filings: 8-K, 10-Q, S-3 & 424B – Health Catalyst

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 11, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Health Catalyst Reports Third Quarter 2026 Results

Nov 5, 2026

8-K

Health Catalyst Appoints Tami Reller to Board of Directors and Audit Chair

Sep 14, 2026

8-K

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Sep 8, 2026

8-K

Health Catalyst Reports Second Quarter 2026 Financial Results

Aug 6, 2026

8-K

Health Catalyst, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jul 17, 2026

8-K

Health Catalyst to Divest Vitalware for $147 Million

Jun 4, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

SHELF OFFERING | Shares amount: 4,245,283 | Share price: $53.00 | Offering amount: $224,999,999.00

Aug 11, 2021

424B5

SHELF OFFERING | Shares amount: 3,963,360 | Share price: $56.77 | Offering amount: $225,000,000.00

Aug 9, 2021

424B4

OFFERING | Shares amount: 7,000,000 | Share price: $26.00 | Offering amount: $182,000,000.00

Jul 25, 2019

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 14, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 12, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 26, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 6, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Nov 25, 2024

Form D - Notice of Exempt Offering of Securities - Item 06b

Aug 15, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jun 3, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jun 3, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

May 19, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 19, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

May 7, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Reller Tami (Reporting)

Oct 5, 2026

Reller Tami (Reporting)

Oct 5, 2026

Kohl Simeon (Reporting)

Sep 16, 2026

Kohl Simeon (Reporting)

Sep 16, 2026

Albert Benjamin (Reporting)

Sep 11, 2026

144

Form 144 - Report of proposed sale of securities

Sep 10, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

May 16, 2024

CORRESP

Form CORRESP - Correspondence

Apr 23, 2024

LETTER

Form UPLOAD - SEC-generated letter

Apr 10, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 25, 2019

CORRESP

Form CORRESP - Correspondence

Jul 23, 2019

CORRESP

Form CORRESP - Correspondence

Jul 23, 2019

Health Catalyst, Inc. HCAT · SEC Filings